JUL 21, 2020 11:42 AM PDT

Investigating New Anti-Blood Clotting Treatments

WRITTEN BY: Jasper Cantrell

When it comes to your cardiovascular health, it is important to look at more than just your heart. The cardiovascular system could be summarized as a pathway for your blood to run through your body. Any issues with the proper flow of blood can cause major damage to the body. These issues can be things such as heart dysfunction, obstruction of a blood vessel, or (the scariest, in my opinion) blood clots.

Blood clots form when there is an injury to the blood vessels. The body responds by combining platelets with fibrin at the wound, where they coagulate and prevent blood loss. However, abnormal blood clots can block blood flow and cause tissue damage. 

Several things can be done to prevent blood clots, from exercising to a healthy diet, but some factors are out of your control. Scientists have sought to identify any biomarkers against the risk of blood clots and have found a few with promise.

The Von Willebrand factor (VWF) is one such biomarker.  It is a small protein involved in the initial blood clot formation caused by high shearing forces. These shearing forces are usually due to high blood flow surrounding clogged arteries. It is already considered a poor prognostic indicator for cardiovascular health, and anti-VWF drugs have some promise for blood clot treatment and prevention. 

A team from the Medical University of Vienna in Austria sought to test a new anti-VWF drug, BT200. They set up blood clotting experiments using endotoxin (the toxic part of bacteria) and desmopressin (a kidney drug) to activate VWF. They would then treat the blood with BT200 and observe how it affected VWF activity.

BT200 treatment managed to inhibit VWF activation in all cases. The most significant find was that effective BT200 dosage was tied to VWF levels. This gives critical dosage information for future studies, and retroactive analysis showed that this characteristic was shared amongst all VWF inhibitors. Conventional clotting inhibitors usually do not catch VWF dependent clotting, so more research is needed into this treatment pathway.

The team concludes, “Even under conditions of stimulated VWF release, BT200 potently inhibits VWF activity and VWF-dependent platelet function. This is in contrast to conventional platelet inhibitors whose effects are compromised by elevated VWF under high shear rates.”

Sources: Nature Scientific Reports, LearnBlood

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
JUN 04, 2020
Cannabis Sciences
How Does Recent Cannabis Use Affect Your Risk of Stroke?
JUN 04, 2020
How Does Recent Cannabis Use Affect Your Risk of Stroke?
Does cannabis use influence stroke risk? Some research says yes; some says no. These “conflicting results” f ...
JUN 27, 2020
Cardiology
Automating the Analysis of the Circle of Willis to Determine Vascular Health
JUN 27, 2020
Automating the Analysis of the Circle of Willis to Determine Vascular Health
The Circle of Willis (CoW) is a vital part of the brain’s anatomy that acts as a junction of blood flow. It i ...
JUN 29, 2020
Neuroscience
Stroke Most Common Brain Side Effect from COVID-19
JUN 29, 2020
Stroke Most Common Brain Side Effect from COVID-19
Researchers from the UK have identified having a stroke as the most common neurological side-effect of COVID-19. They al ...
JUL 21, 2020
Clinical & Molecular DX
A Lab on a Chip Could Save Your Life in an Emergency
JUL 21, 2020
A Lab on a Chip Could Save Your Life in an Emergency
Picture this: a hiker on a backcountry trail falls down a rocky embankment, and is left with a deep gash on the leg afte ...
JUL 25, 2020
Cardiology
Neurofibromatosis and How It Affects Heart Health
JUL 25, 2020
Neurofibromatosis and How It Affects Heart Health
Genetic diseases are persistent and often cause minor issues that can develop into more prominent problems later. Take n ...
AUG 27, 2020
Immunology
A Seaweed-Inspired Shuttle for Delivering a Stem Cell Cargo
AUG 27, 2020
A Seaweed-Inspired Shuttle for Delivering a Stem Cell Cargo
  Living medicines in the form of stem cell therapies have immense potential for their ability to regenerate and he ...
Loading Comments...